Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
Xenical 120 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. The capsule has a turquoise cap and turquoise body bearing the imprint of “XENICAL 120”. |
Each hard capsule contains 120 mg orlistat.
For a full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Orlistat |
Orlistat is a potent, specific and long-acting inhibitor of gastrointestinal lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine site of the gastric and pancreatic lipases. The inactivated enzyme is thus unavailable to hydrolyse dietary fat, in the form of triglycerides, into absorbable free fatty acids and monoglycerides. |
| List of Excipients |
|---|
|
Capsule filling: Microcrystalline cellulose (E460) Capsule shell: Gelatine |
PVC/PVDC blisters containing 21, 42 and 84 hard capsules. Glass bottles with desiccant containing 21, 42 and 84 hard capsules.
Not all pack sizes may be marketed.
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
EU/1/98/071/001-006
Date of first authorisation: 29 July 1998
Date of latest renewal: 17 June 2008
| Drug | Countries | |
|---|---|---|
| XENICAL | Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
